Connect With Us  

Latest News

  • FDA Approves LINX® System for the Treatment of Reflux Disease

    March 2012

    Torax Medical today announced that the U.S. Food and Drug Administration (FDA) approved the LINX® Reflux Management System for use in patients diagnosed with Gastroesophageal Reflux Disease (GERD).

  • Torax Medical Uses Social Media Channels as a Resource for UK Reflux Sufferers

    December 2011

    If you are a fan of social media, you will be interested to hear that Torax now have a You Tube, Twitter and Facebook account set up for the LINX Reflux Management System. Aimed at UK reflux sufferers, the Facebook fan page contains general info about reflux, plus news about the LINX Reflux Management System. The You Tube page has a selection of LINX videos and the Twitter page has some exciting updates relating to Torax Medical and the LINX System in the UK.

    Twitter  YouTube

  • IES Congress Milan, Italy

    November 2011

    The IES (Innovation in Esophageal Surgery) conference took place at the University of Milan Medical School on 28th and 29th November 2011, with over 100 Upper GI Surgeons from around the world in attendance. Prof Luigi Bonavina demonstrated how the LINX System is placed in a live procedure broadcast via video link to the main auditorium. Prof Bonavina has carried out over 85 LINX procedures since 2007. There was plenty of positive feedback from the attendees, many of whom were interested in offering the LINX System as a solution their GORD patients.

  • Meeting at The Royal College of Physicians in London

    September 2011

    On 22nd September 2011 Torax held a meeting at The Royal College of Physicians in London to discuss the LINX Reflux Management System with select Private GP's and Gastroenterologists. The attendees were invited due to their interest in the treatment of chronic reflux disease to discuss how the LINX System could benefit their patients. First to speak at the meeting was Dr Anthony Hobson from the Neurogastroenterology Diagnostics Centre who discussed the latest technology involved in the diagnosis of reflux disease. Dr Peter Fairclough, a Gastroenterologist, then talked about patient selection for the LINX System, followed by Consultant Upper GI Surgeon Mr Ameet Patel who presented the LINX System clinical data. Finally Dr David Ashton from the Reflux Centre discussed the results of the 11 LINX cases carried out in the UK since April this year. The meeting was an ideal opportunity to educate physicians about the LINX Reflux Management System as a new option for the management of chronic reflux disease.

  • LINX Spring Course 2011

    May 2011

    On the 23rd May 2011, the UK and Germany's leading Upper GI Surgeons and Gastroenterologists gathered in Frankfurt for the LINX® Spring Course. The attendees were specially selected for their expertise in the treatment of chronic reflux disease and their recognition of the need for a new treatment option. The meeting was led by Dr. Tom DeMeester, the world authority on GERD and a key advisor in the development of the LINX Reflux Management System. Todd Berg, Torax's CEO, discussed the results of the pivotal trial data recently submitted to the FDA. Prof Luigi Bonavina presented the results of his four years of experience, followed by Prof Martin Schilling and Prof Karl-Hermann Fuchs who shared their experiences of implanting the LINX System in their patients. With around 200 patients treated to date, Torax continues to work with key centres to ensure more patients have access to the LINX System as an alternative to long-term drug therapy for the treatment of reflux disease.

  • Implant Technique for the FENIX System presented at 2011 ASCRS meeting

    May 2011

    The video "Implantation of a Magnetic Anal Sphincter for the Treatment of Fecal Incontinence" was presented by Professor Paul-Antoine Lehur at the American Society of Colon and Rectal Surgeons Annual Scientific Meeting in Vancouver.

  • Data on the FENIX System Presented at 2011 ASCRS meeting

    May 2011

    The abstract "The Magnetic Anal Sphincter versus the Artificial Bowel Sphincter - A Comparison of 2 Treatments for Fecal Incontinence" was presented at the American Society of Colon and Rectal Surgeons Annual Scientific Meeting in Vancouver.

  • First Patient in UK Implanted with the LINX Reflux Management System

    April 2011

    Lewis Tyler, a Network Rail Engineer from Middlesex has become the first person in the UK to have the LINX® Reflux Management System. A week after the operation Lewis said "It is less than a week since I had the procedure so it is still early days however the throat pain from my reflux has gone and I am no longer having indigestion."

  • Torax Study Published in Annals of Surgery

    Fall 2010

    The manuscript "Laparoscopic Sphincter Augmentation Device Eliminates Reflux Symptoms and Normalizes Esophageal Acid Exposure: One and Two Year Results of a Feasibility Trial" by Professor Luigi Bonavina, et al, was published in the 2010 Fall issue of Annals of Surgery.

  • Torax Data Presented at ISDE Conference

    September 2010

    The "Sphincter Augmentation Device Addresses GERD Therapy Gap" abstract was presented at the September 2010 ISDE Conference by Dr. John Lipham.

  • Award Received for Presentation on Magnetic Anal Sphincter

    May 2010

    The presentation of "Magnetic Anal Sphincter for the Treatment of Fecal Incontinence" by Dr. Steen Buntzen at the 2010 ASCRS Annual Meeting won the Pittsburgh Society of Colon and Rectal Surgeons Award, Karl A. Zimmerman, MD Award for the Anorectal Surgery Podium Presentation.

  • DDW Poster of Distinction Award Received

    May 2010

    Dr. Bob Ganz's poster "Magnetic Sphincter Augmentation is Safe and Effective for the Long-term Treatment of Gastroesophageal Reflux Disease (GERD)" received a poster of distinction award at the 2010 DDW Conference.

  • Torax Medical Receives CE Mark for its LINX Reflux Management System

    April 2010

    Torax Medical Inc. has received CE Mark for its LINX® Reflux Management System. The company has started commercial launch of the LINX device in select centers in Europe.

  • Torax Completes LINX Pivotal Trial Enrollment Ahead of Plan


    Enrollment in the LINX® Reflux Management Study was completed in just nine months with 100 patients enrolled in 15 centers across the United States. Follow-up data will be collected at 3-month, 6-month and 1-year time points.